Hennion & Walsh Asset Management’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-138,200
| Closed | -$583K | – | 784 |
|
|
2022
Q3 | $583K | Sell |
138,200
-7,808
| -5% | -$32.9K | 0.04% | 450 |
|
|
2022
Q2 | $407K | Sell |
146,008
-137,946
| -49% | -$385K | 0.03% | 535 |
|
|
2022
Q1 | $1.62M | Sell |
283,954
-12,098
| -4% | -$69.2K | 0.09% | 249 |
|
|
2021
Q4 | $2.7M | Sell |
296,052
-71,065
| -19% | -$649K | 0.13% | 198 |
|
|
2021
Q3 | $3.92M | Sell |
367,117
-13,125
| -3% | -$140K | 0.21% | 132 |
|
|
2021
Q2 | $5.9M | Sell |
380,242
-13,239
| -3% | -$205K | 0.31% | 73 |
|
|
2021
Q1 | $6.38M | Buy |
+393,481
| New | +$6.38M | 0.38% | 61 |
|